INTERNATIONAL PATENT: KAOHSIUNG MEDICAL UNIVERSITY, 高雄医学大学 FILES APPLICATION FOR "MITOCHONDRIAL-TARGETED DRUG DR20 AND EFFICACY THEREOF IN TREATING PULMONARY ARTERIAL HYPERTENSION, PULMONARY FIBROSIS AND LUNG CANCER"

GENEVA, May 18 -- KAOHSIUNG MEDICAL UNIVERSITY (No.100, Shiquan 1st Rd., Sanmin Dist., Kaohsiung CityTaiwan 807), 高雄医学大学 (中国台湾省高雄市三民区十全一路100号) filed a patent application (PCT/CN2025/132888) for "MITOCHONDRIAL-TARGETED DRUG DR20 AND EFFICACY THEREOF IN TREATING PULMONARY ARTERIAL HYPERTENSION, PULMONARY FIBROSIS, AND LUNG CANCER" on Nov 06, 2025. With publication no. WO/2026/098531, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the Wor...